Navigation Links
No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
Date:6/18/2008

WASHINGTON, June 18 /PRNewswire/ -- Georgetown University, Gentag, Inc., and Science Applications International Corporation (SAIC, NYSE: SAI), have combined forces to develop a non-invasive method for glucose measurement. The three technology leaders agreed to combine their respective intellectual property (IP) and expertise to create a new method to monitor glucose, using disposable skin patches with wireless sensors and cell phones. The resulting products could eliminate the need for finger pricking with lancets to draw blood for people of all ages with diabetes.

"This alliance provides an excellent example of cooperation between academia and industry to bring creative healthcare solutions to the marketplace," said Claudia Stewart, Vice President of Technology Commercialization at Georgetown University.

The combined technology will enable the development of a unique new platform and approach for glucose monitoring and insulin delivery using cell phones. One potential market application could be a disposable, wireless skin patch that measures glucose levels and reports those levels to a cell phone that could also wirelessly control an insulin pump.

By using soft, flexible skin patches, combined with new sensor-chip technology, the traditional pain and discomfort of the current "finger prick" technology could be dramatically reduced or eliminated. The patches would be designed to provide readings once every hour for a 24-hour period. Using cell phones as readers would allow for convenience of a device many already use and are familiar with, as well as many other benefits, including emergency geolocation of patients.

"We expect that this new, painless, disposable, wireless, glucose sensor technology will significantly improve diabetes monitoring worldwide," said John Peeters, founder and president of Gentag, Inc.

With funding from the Defense Advanced Research Projects Agency (DARPA) at the Department of Defense, John Currie,
'/>"/>

SOURCE Georgetown University; Gentag, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Georgetown researchers find stem cell marker controls 2 key cancer pathways
2. Georgetown U student selected for prestigious Bouchet Society
3. Georgetown leads major effort to combat disparities in DC stroke care
4. New USAID grant helps Georgetown meet unmet family planning needs worldwide
5. Hebrew University research on octopuses sheds light on memory
6. Gesture interface device developed by Ben-Gurion University of the Negev
7. $10 million gift will retain and recruit world-class researchers to University at Buffalo
8. The University of Arizona Program in Integrative Medicine Earns Center of Excellence Designation
9. Nursing Entrepreneur Whose Business Career Was Spurred by Venture Training is Honored with Alumna Award from Case Western Reserve University
10. Duke University Health System to Implement Clinically Optimized, Advanced Authentication Solution From Sentillion
11. Canine Cancer Web Exclusive for Dog Owners and Lovers, Presented by Morris Animal Foundation - Features Colorado State and Cornell University Veterinary Cancer Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
....1 lakh chickens in 354 villages in Jalgaon distri...d people that there was no cause for panic.// Dist...s had been identified as being within a radius of ...Animal Diseases Laboratory in Bhopal. This third ...
...some people may be due to their inability of the b... disorder (ASD), it is characterised by varying de...l interaction and restricted, repetitive and stere...ur. It had been thought that lack of social skill...
... to the fumes of solvents used in house renovation...and lacquers//, could give rise to allergies in yo...al medical specialist at Germany's environmental a...novation work to their husbands or hired professio...
... people in North Shropshire and Wales and funded b...r// drug Herceptin, free to the Welsh breast cance... at ?47,000, will have to be borne by the other ca... With effect from February, all Welsh local Healt...
Other Medicine News:
(Date:10/7/2008)... Prevented Immunologic Changes Induced by ...ditional Data Indicates Potential in Treating Infl...Newswire/ -- Alba Therapeutics Corporation,present...the American,College of Gastroenterology (ACG) 200...1001-004, the first Phase IIa trial conducted in c...
(Date:10/7/2008)...t ACG Annual Scientific Meeting -, ORLANDO, Fla.,...euticals, Inc. (formerly Microbia, Inc.) and Fores... the presentation of results from a Phase,2b study...0 patients with,irritable bowel syndrome with cons...hat once- daily oral dosing of linaclotide, across...
(Date:10/7/2008)...ed Placebo-Controlled Phase II Study Shows ...val., MOUNTAIN VIEW, California, October 7 /PRNew...the mature Phase II data from the,therapeutic pros...d been,obtained as part of the recently entered pa... in the US., The results from the Phase II prospe...
(Date:10/7/2008)...7 /-, - 125 Patient, Prosp...y,Shows Statistically Significant Improved Overall...mature phase II data from the,therapeutic prostate...en,obtained as part of the recently entered partne...the US., The results from the Phase II prospectiv...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Resverlogix Notice of Conference Call 26 Webcast 5051 1Resverlogix Notice of Conference Call 26 Webcast 5051 2Napping Habits Tied to Sleep Disorders 18228 1Napping Habits Tied to Sleep Disorders 18228 2Studies test new approaches to islet transplantation 18223 1Studies test new approaches to islet transplantation 18223 2Studies test new approaches to islet transplantation 18223 3Studies test new approaches to islet transplantation 18223 4Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 1Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 2Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 3Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 4Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 5Governor Rendell Says Passage of PA ABC Would Help More Than 36 000 Uninsured Citizens Living in the Lehigh Valley 18218 6
...y company Apollo,Life Sciences has released result...e vaccine technology, which delivers tetanus,vacci...ed for an,injection. , According to Apollo CEO Joh...bility that flu injections may soon be a thing of ...ng, people around,Australia are considering gettin...
...ra AG announced,that an interim report regarding t...is was received today from an independent review,c...tigate the,efficacy and safety of several doses of...received today refer to the clinical results,eight... the results,after twelve weeks will follow. , The...
Other Medicine Technology:Apollo develops needle-free topical vaccine 2Apollo develops needle-free topical vaccine 3Apollo develops needle-free topical vaccine 4Apollo develops needle-free topical vaccine 5
For processing mini spin columns on QIAvac 24;
DNA/RNA preparation in 8-multi channels
...nits with hydrophobic PTFE membranes,Millex filter...eal for the sterilizing filtration of gases, for v...or clarifying organic solutions. Ready-to-use ster...ifferent outlet connections; other filter units ca...
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory.
Medicine Products: